Myeloid Malignancy
📧 Sign up to get email alerts when something new happens for Myeloid Malignancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant [Phase 1, Phase 2]
This clinical trial examines maintenance therapy with decitabine and venetoclax after allogeneic stem cell transplant. It is a Phase 1/2 stu…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML [Phase 2]
A Phase 2 clinical trial is evaluating a combination of mitoxantrone hydrochloride liposome injection, cytarabine, and venetoclax for relaps…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies [Phase 2]
Phase 2 clinical trial evaluating venetoclax plus reduced-intensity conditioning allogeneic stem cell transplantation in elderly patients wi…
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation [Phase 2]
A Phase 2 pilot trial evaluating adding clofarabine to standard busulfan/fludarabine conditioning for allogeneic hematopoietic cell transpla…